Keep up to date with every new upload!

Join free & follow JNNP podcast
Share
  • 5 years ago
The future of glioblastoma therapy

The future of glioblastoma therapy

Despite current standard care for glioblastoma being aggressive, mean survival is around 14 months. Clark Chen (director of Clinical Neuro-oncology, Beth Israel Deaconess Medical Center, Boston) argues we need a better understanding of the therapeutic concepts that have evolved over the past three decades to develop treatment, and in a JNNP article this month he lays out seven of these key ideas. Peter Warnke (JNNP associate editor) discusses them with him.See also:Key concepts in glioblastoma therapy http://tinyurl.com/ao8g8m3

Comments